These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 16752751

  • 1. [Characterization of a Chrysemonas luteola strain isolated from a healthy carrier and investigation of pathogenicity, virulence and antibiotic resistance factors through in vitro and in vivo studies].
    Israil A, Balotescu C, Alexandru I.
    Bacteriol Virusol Parazitol Epidemiol; 2004; 49(1-2):43-7. PubMed ID: 16752751
    [No Abstract] [Full Text] [Related]

  • 2. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
    Cavallo JD, Mérens A.
    Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
    [Abstract] [Full Text] [Related]

  • 3. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia.
    Ohlasova D, Kmet V, Niks M.
    Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230
    [No Abstract] [Full Text] [Related]

  • 4. In vitro activity of azithromycin as an antipseudomonal agent.
    Mahapatra A, Mahapatra A, Padhi S, Mahapatro S, Ghosh SK.
    Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
    [No Abstract] [Full Text] [Related]

  • 5. Part II. Introduction to the beta-lactam antibiotics.
    Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA.
    J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
    [No Abstract] [Full Text] [Related]

  • 6. Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.
    Fodor E, Hajdú E, Nagy E.
    Int J Antimicrob Agents; 2005 Feb; 25(2):183-4. PubMed ID: 15664494
    [No Abstract] [Full Text] [Related]

  • 7. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
    Wolter DJ, Acquazzino D, Goering RV, Sammut P, Khalaf N, Hanson ND.
    Clin Infect Dis; 2008 Jun 15; 46(12):e137-41. PubMed ID: 18462098
    [Abstract] [Full Text] [Related]

  • 8. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
    Hawser SP, Bouchillon SK, Hoban DJ, Hackel M, Johnson JL, Badal RE.
    Int J Antimicrob Agents; 2009 Oct 15; 34(4):384-5. PubMed ID: 19560904
    [No Abstract] [Full Text] [Related]

  • 9. Potential of doripenem for the treatment of infections with multidrug-resistant Pseudomonas spp.
    Naesens R, Jansens H, Goossens H, Ieven M, Vlieghe E.
    Int J Antimicrob Agents; 2010 May 15; 35(5):514-5. PubMed ID: 20188527
    [No Abstract] [Full Text] [Related]

  • 10. A comparative study on the convulsant activity of carbapenems and beta-lactams.
    Shimada J, Hori S, Kanemitsu K, Shoji Y, Nakashio S, Yanagawa A.
    Drugs Exp Clin Res; 1992 May 15; 18(9):377-81. PubMed ID: 1338591
    [Abstract] [Full Text] [Related]

  • 11. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fischer I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C.
    J Antimicrob Chemother; 2008 Aug 15; 62(2):316-23. PubMed ID: 18467306
    [Abstract] [Full Text] [Related]

  • 12. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
    Shah PM.
    Int J Antimicrob Agents; 2009 Oct 15; 34(4):381. PubMed ID: 19502012
    [No Abstract] [Full Text] [Related]

  • 13. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP, Soares FC, Superti SV, Silbert S, Silva FM, Barth AL.
    Int J Antimicrob Agents; 2007 Aug 15; 30(2):187-9. PubMed ID: 17452093
    [No Abstract] [Full Text] [Related]

  • 14. A carbapenem-susceptible Pseudomonas aeruginosa strain carrying the bla(SPM) gene.
    Pellegrino FL, Casali N, Nouér SA, Riley LW, Moreira BM.
    Diagn Microbiol Infect Dis; 2008 Jun 15; 61(2):214-6. PubMed ID: 18308497
    [Abstract] [Full Text] [Related]

  • 15. Carbapenems in the USA: focus on doripenem.
    Lister PD.
    Expert Rev Anti Infect Ther; 2007 Oct 15; 5(5):793-809. PubMed ID: 17914914
    [Abstract] [Full Text] [Related]

  • 16. Pseudomonas cepacia in the West of Scotland.
    Henderson A, Byatt ME.
    Health Bull (Edinb); 1974 May 15; 32(3):100-2. PubMed ID: 4418941
    [No Abstract] [Full Text] [Related]

  • 17. [The virulence and antibiotic resistance of Escherichia isolated from man].
    Bondarenko VI, Ferents AI, Kolesnikov VG, Buraia TA.
    Mikrobiol Zh (1978); 1990 May 15; 52(3):66-70. PubMed ID: 2215289
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Addressing the challenge of extended-spectrum beta-lactamases.
    Zahar JR, Lortholary O, Martin C, Potel G, Plesiat P, Nordmann P.
    Curr Opin Investig Drugs; 2009 Feb 15; 10(2):172-80. PubMed ID: 19197795
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.